137 related articles for article (PubMed ID: 24368589)
1. Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
Balood M; Mesbah-Namin SA; Sanati MH; Zahednasab H; Sahraian MA; Ataei M
Mol Biol Rep; 2014 Feb; 41(2):613-6. PubMed ID: 24368589
[TBL] [Abstract][Full Text] [Related]
2. IkappaBalpha promoter polymorphisms in patients with Behçet's disease.
Hung YH; Wu CC; Ou TT; Lin CH; Li RN; Lin YC; Tsai WC; Liu HW; Yen JH
Dis Markers; 2010; 28(1):55-62. PubMed ID: 20164548
[TBL] [Abstract][Full Text] [Related]
3. IkBα promoter polymorphisms in patients with ankylosing spondylitis.
Hung YH; Ou TT; Lin CH; Li RN; Lin YC; Tsai WC; Liu HW; Yen JH
Rheumatol Int; 2009 Nov; 30(1):93-7. PubMed ID: 19363678
[TBL] [Abstract][Full Text] [Related]
4. IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.
Ou TT; Lin CH; Lin YC; Li RN; Tsai WC; Liu HW; Yen JH
J Clin Immunol; 2008 Sep; 28(5):440-4. PubMed ID: 18600435
[TBL] [Abstract][Full Text] [Related]
5. I kappa B alpha promoter polymorphisms in patients with systemic lupus erythematosus.
Lin CH; Wang SC; Ou TT; Li RN; Tsai WC; Liu HW; Yen JH
J Clin Immunol; 2008 May; 28(3):207-13. PubMed ID: 18071880
[TBL] [Abstract][Full Text] [Related]
6. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
[TBL] [Abstract][Full Text] [Related]
7. IkappaBalpha promoter polymorphisms in patients with rheumatoid arthritis.
Lin CH; Ou TT; Wu CC; Tsai WC; Liu HW; Yen JH
Int J Immunogenet; 2007 Feb; 34(1):51-4. PubMed ID: 17284228
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor kappaB-alpha haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians.
Zhai R; Zhou W; Gong MN; Thompson BT; Su L; Yu C; Kraft P; Christiani DC
Crit Care Med; 2007 Mar; 35(3):893-8. PubMed ID: 17235259
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor IkappaBalpha promoter functional polymorphisms in patients with rheumatoid arthritis.
Li RN; Hung YH; Lin CH; Chen YH; Yen JH
J Clin Immunol; 2010 Sep; 30(5):676-80. PubMed ID: 20563630
[TBL] [Abstract][Full Text] [Related]
10. Combination of interleukin-10 gene promoter polymorphisms with HLA-DRB1*15 allele is associated with multiple sclerosis.
Shahbazi M; Abadi JSA; Roshandel D; Koochaki M; Amiri H; Kohansal R; Baghbanian SM; Zamani M
Indian J Med Res; 2017 Jun; 145(6):746-752. PubMed ID: 29067976
[TBL] [Abstract][Full Text] [Related]
11. Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.
Rahimi Z; Abdan Z; Rahimi Z; Razazian N; Shiri H; Vaisi-Raygani A; Shakiba E; Vessal M; Moradi MT
Immunol Invest; 2016 Aug; 45(6):543-52. PubMed ID: 27409770
[TBL] [Abstract][Full Text] [Related]
12. Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancer.
Tan SC; Suzairi MS; Aizat AA; Aminudin MM; Nurfatimah MS; Bhavaraju VM; Biswal BM; Ankathil R
Med Oncol; 2013 Dec; 30(4):693. PubMed ID: 23996241
[TBL] [Abstract][Full Text] [Related]
13. CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis.
Yousefipour G; Erfani N; Momtahan M; Moghaddasi H; Ghaderi A
Acta Neurol Scand; 2009 Dec; 120(6):424-9. PubMed ID: 19737153
[TBL] [Abstract][Full Text] [Related]
14. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
Sayad A
Int J Immunogenet; 2014 Aug; 41(4):330-4. PubMed ID: 24919928
[TBL] [Abstract][Full Text] [Related]
15. IκBα polymorphisms were associated with increased risk of gastric cancer in a southern Chinese population: a case-control study.
Wang S; Zhang M; Zeng Z; Tian L; Wu K; Chu J; Fan D; Hu P; Sung JJ; Yu J
Life Sci; 2011 Apr; 88(17-18):792-7. PubMed ID: 21376060
[TBL] [Abstract][Full Text] [Related]
16. Association study of two functional single nucleotide polymorphisms of neuropeptide y gene with multiple sclerosis.
Mohammadi SM; Shirvani Farsani Z; Dosti R; Sahraian MA; Behmanesh M
Neuropeptides; 2016 Dec; 60():45-50. PubMed ID: 27559040
[TBL] [Abstract][Full Text] [Related]
17. Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population.
Simsek H; Geckin H; Sensoz NP; List EO; Arman A
J Mol Neurosci; 2019 Jan; 67(1):38-47. PubMed ID: 30443838
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of NFκB1-94ins/delATTG and NFκBIA-881A/G genes in Egyptian patients with colorectal cancer.
Youssef MR; Attia ZI; El-Baz RA; Roshdy S; Settin A
Fam Cancer; 2017 Oct; 16(4):517-524. PubMed ID: 28389768
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in the FOXP3 gene are associated with increased risk of relapsing-remitting multiple sclerosis.
Eftekharian MM; Sayad A; Omrani MD; Ghannad MS; Noroozi R; Mazdeh M; Mirfakhraie R; Movafagh A; Roshanaei G; Azimi T; Inoko H; Taheri M
Hum Antibodies; 2016; 24(3-4):85-90. PubMed ID: 27792007
[TBL] [Abstract][Full Text] [Related]
20. IkappaBalpha polymorphism at promoter region (rs2233408) influences the susceptibility of gastric cancer in Chinese.
Wang S; Tian L; Zeng Z; Zhang M; Wu K; Chen M; Fan D; Hu P; Sung JJ; Yu J
BMC Gastroenterol; 2010 Feb; 10():15. PubMed ID: 20132559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
